BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18204336)

  • 1. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
    Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA
    J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
    Smith RC; Rachakonda S; Dwivedi S; Davis JM
    Psychiatry Res; 2012 Oct; 199(3):159-63. PubMed ID: 22475524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes.
    Noordsy DL; Glynn SM; Sugar CA; O'Keefe CD; Marder SR
    J Psychiatr Res; 2017 Dec; 95():299-307. PubMed ID: 28942217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications.
    Lasser RA; Mao L; Gharabawi G
    Schizophr Res; 2004 Feb; 66(2-3):163-7. PubMed ID: 15061249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population.
    Rado J; von Ammon Cavanaugh S
    J Clin Psychopharmacol; 2016 Apr; 36(2):163-8. PubMed ID: 26872112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    Biol Psychiatry; 2009 Apr; 65(7):607-13. PubMed ID: 19103435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
    Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
    J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
    J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight effects associated with antipsychotics: a comprehensive database analysis.
    Parsons B; Allison DB; Loebel A; Williams K; Giller E; Romano S; Siu C
    Schizophr Res; 2009 May; 110(1-3):103-10. PubMed ID: 19321312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.
    Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
    J Neural Transm (Vienna); 2007 Feb; 114(2):273-80. PubMed ID: 17109073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects.
    Mitchell M; Riesenberg R; Bari MA; Marquez E; Kurtz D; Falk D; Hardy T; Taylor CC; Mitchell CP; Cavazzoni P
    Clin Ther; 2006 Jun; 28(6):881-92. PubMed ID: 16860171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.
    Karagianis J; Grossman L; Landry J; Reed VA; de Haan L; Maguire GA; Hoffmann VP; Milev R
    Schizophr Res; 2009 Aug; 113(1):41-8. PubMed ID: 19535229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.
    Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.